REFERENCES
- WHO. Global tuberculosis control. Geneva: World Health Organization, 2010. http://whglibdoc.who.int/publications/2010/ 9789241564069_eng.pdf (accessed Dec 15, 2010)
- Lawn SD, Zumla Al. Tuberculosis. Lancet. 2011 Mar 17. [Epub ahead of print].
- Cordonnier C, Martino R, Trabasso P, Held TK, Akan H, Ward MS, et al. Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients. Clin Infect Dis 2004; 38: 1229–1236.
- Ip MS, Yuen KY, Woo PC, Luk WK, Tsang KW, Lam WK, et al. Risk factors for pulmonary tuberculosis in bone marrow transplant recipients. Am J Respir Crit Care Med 1998; 158: 1173–1177.
- Martino R, Martinez C, Brunet S, Sureda A, Lopez R, Domingo-AlbOs A. Tuberculosis in bone marrow transplant recipients: report of two cases and review of the literature. Bone Marrow Transplant 1996; 18: 809–812.
- de la Cámara R, Martino R, Granados E, Rodriguez-Salvanés FJ, Ro-vira M, Cabrera R, et al. Tuberculosis after hematopoietic stem cell trans-plantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation. Bone Marrow Transplant 2000; 26 (3): 291–298.
- Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canenos GP, Young RC, Rosenberg SA, Coltman CA, Tubiana M. Report of a committee con-vened to discuss the evaluation and staging of patients with Hodgkin's dis-ease: Cotswolds meeting. J Clin Oncol. 1989; 7 (11): 1630–1636.
- Bezuidenhout J, Schneider JW. Pathology and pathogenesis of tuber-culosis. In: Schaaf S, Zumla A, eds. Tuberculosis: a comprehensive clinical reference. Philadelphia, PA: Saunders, 2009: 117–128.
- Mackall CL, Fleisher TA, Brown MR, Magrath IT, Shad AT, Horowitz ME, et al. Lymphocyte depletion during treatment with intensive chemother-apy for cancer. Blood 1994; 84: 2221–2228.